Viewing Study NCT06732232


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2025-12-25 @ 7:37 PM
Study NCT ID: NCT06732232
Status: RECRUITING
Last Update Posted: 2024-12-13
First Post: 2024-11-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Sponsor: Shanghai Cell Therapy Group Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module